Past Bid Detail Page

User Notifications

All caught up!
No new notifications.
Hi, Pic G
G
Guest User
Sign In Sign Up

Federal Bid

Last Updated on 06 Jul 2018 at 8 AM
Justification and Approval
Location Unknown

PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers

Solicitation ID N01CN5503-16
Source Signup to get source link
Posted Date 05 Jul 2018 at 9 PM
Archive Date 06 Jul 2018 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office National Cancer Institute, Office Of Acquisitions - Shady Grove
Agency Department Of Health And Human Services
Location United states
Please see attached Justification & Approval for PREVENT Preclinical Drug Development: Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Bid Protests Not Available

Similar Past Bids

Preclinical Efficacy and Intermediate Endpoint Biomarkers
Location Unknown 15 Dec 2011 at 8 PM
Preclinical Efficacy and Intermediate Endpoint Biomarkers
Location Unknown 11 Apr 2012 at 9 PM
Preclinical Efficacy and Intermediate Endpoint Biomarkers
Location Unknown 14 Mar 2012 at 1 PM
Preclinical PREVENT Cancer Program: “Preclinical Efficacy and Intermediate Endpoint Biomarkers
Location Unknown 25 Jul 2014 at 4 PM
Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers
Location Unknown 05 Mar 2015 at 2 PM

Similar Opportunities

Initial Efficacy Testing of Autoclaves
Lemont Illinois 11 Jul 2025 at 5 PM
PLATE, INTERMEDIATE,
Location Unknown 11 Jul 2025 at 4 AM
AOUSC's Endpoint Protection Solution RFI
Washington District of columbia 23 Jul 2025 at 6 PM
25--PLATE,INTERMEDIATE,
Columbus Ohio 11 Jul 2025 at 4 AM
FUEL OIL, INTERMEDIATE
Location Unknown 30 Jul 2025 at 4 AM
2021 © BidFortune
About Contact